US Authorizes Pfizer COVID-19 Booster for Those above 65, at High-Risk |
Clinical News
eMediNexus Coverage from: 
US Authorizes Pfizer COVID-19 Booster for Those above 65, at High-Risk

0 Read Comments                

The United States has authorized the use of Pfizer COVID-19 vaccine boosters among individuals over 65 years of age and adults who have a high risk of severe disease and people in high-exposure occupations.A significant proportion of the population will now be eligible for a third vaccine dose six months after receiving the second jab. The authorization has come after an independent expert panel voted recommending the move last week. The panel had dismissed an initial plan to approve Pfizer boos...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now